Asian Conference on Diarrhoeal Disease and Nutrition (ASCODD)
30 October - 01 November, 2017  |  Kochi, India

    Session Programme

    Oct 30-Nov 1, 2017 Kochi, India

      Day 1, Oct 30,2017

      Opening Session

      9:00 -9:10


      9:10 -9:30


      9:30 -9:40


      9:40 -9: 50


      9:50 -10: 15

      Welcome Address:  Prof. M. Radhakrishna Pillai, Organizing Chair & Director RGCB


      Presidential Address: President ASCODD:  Professor N.K Ganguly


      Special Address Past President of ASCODD: Professor KMS Aziz


      Special Address Incoming President   ASCODD: Dr. Firdausi Qadri


      Key note Lecture: Prevention of Cholera: Dr. John D Clemens

      10:15 -10:45

      Tea / coffee break

      10:45- 12:45

      Session 1: Understanding of enteric pathogens and NGS (5X20+20 discussion)

      Session Chair: Prof. Gordon Dougan and Prof. N.K Ganguly


    1. Prof. Gordon Dougan, Sanger Institute, UK
      The genomics of enteric pathogens 
    2. Prof. Niyaz Ahmed, icddrb, Dhaka, Bangladesh
      Enteric pathogens in High resolution: Novel insights into bacteria- host interaction, dynamics & survival mechanisms
    3. Prof. Colin Stien, University of Maryland, USA
      Using metagenome and whole genome sequencing
    4. Prof. Lothar H Wieler, Robert Koch Institute, Berlin, Germany
      Surveillance of Antimicrobial Resistance in the German Public health Institute
    5. Dr. T. Ramamurthy, THSTI, Faridabad, India
      Role of WGS in the Global Epidemiology of Enteric Pathogens



      13:45 -15:30

      Session 2a: Microbiota (5X15+15discussion)

      Session Chair: Dr. GB Nair,
                                   Dr. Amit Ghosh


    1. Dr. Vineet Ahuja, AIIMS, New Delhi
      Gut Microbiome manipulation strategies: From Science into Practice
    2. Dr. Tarini Shankar Ghosh, THSTI, Faridabad, India
      Gut Microbial Ecology of the Indian Population: Implications for Health and Disease
    3. Dr. Trevor Lawley, Wellcome Trust Sanger Institute
      Culturing the "unculturable" to enable functional and therapeutic opportunities with the human microbiota
    4. Dr. Ankur Mutreja, Wellcome Trust Sanger Institute, UK
      Genomics, Metagenomics and their potential use in practice
    5. Dr. Munirul Alam, icddr,b, Dhaka
      Cause and Effect of Gut Microbiota Perturbation in children of Bangladesh
    6. Dr. Valentina Picot, Foundation Merieux, France
      An overview of FMx enteric disease activities, advocacy & research

     Session 2b: Diarrhoeal Disease Surveillance (5X15+15 discussion)

      Session Chair: Dr. Shanta Dutta,
                                   Dr. Sanjukta Sen Gupta


    1. Dr. Dominique Legros, WHO headquarters, Geneva
      Cholera surveillance: laboratory capacities, RDTs & reporting of cases to WHO
    2. Dr. Martin Mengel
      Creating networks for surveillance for diarrheal diseases: Practical difficulties and way forward
    3. Asish Mukhopadhyay: NICED, Kolkata
      Polymyxin B Sensitive El tor Vibrio cholera 01 another major blow to biotyping determinants
    4. Dr Girish Kumar, National Institute of Epidemiology, Chennai 
      National Rotavirus Surveillance Network: From Baseline Evidence to Vaccine Rollout
    5. Dr. B. B. Pal, RMRC
      Bhubaneshwar Endemicity of Cholera in Odisha
    6. 6. Bharat Biotech

      15:30- 16:00

      Tea /coffee and poster viewing

      16:00 -18:00

      Nutrition (5X20+20discussion)

      Session Chair: Dr. Tahmeed Ahmed,

                                    Dr. Shafiqul Alam Sarker


    1. Dr. Keith West, Johns Hopkins University, USA
      Improving maternal nutrition in Asia
    2. Prof. Alan Jackson, University of Southampton, USA
      Childhood stunting: what should Asia do to reduce the burden?
    3. Dr. Daniel Roth, Hospital for SickKids, Toronto, Canada
      Maternal and infant vitamin D deficiency: is there a need to intervene in Asia?
    4. Dr. Mustafa Mahfuz, icddr,b, Bangladesh 
      Environmental enteropathy – a myth or a reality
    5. Dr. Tahmeed Ahmed, icddr,b, Bangladesh
      Gut microbiota and its implication on pathogenesis and treatment of childhood malnutrition



      Poster viewing and Evaluation




      Day 2 Oct 31, 2017



      Session 1: Gut Immune system & Oral Vaccines(5X20+20 discussion)

      Session Chair: Dr. John D Clemens,

                                    Dr. Trevor Lawley

    1. Prof. Jan Holmgren, University of Gothenburg, Sweden
      Intestinal immunity and Oral Cholera Vaccines
    2. Prof. Cecil Czerkinsky, INSERM, Nice, France
      Intestinal immunity after sequential oral-parenteral polio vaccination in children from lesser developed countries
    3. Suman Kanungo: NICED, Kolkata
      Oral Cholera Vaccines: From Experience to Evidence in Controlling Cholera in Endemic Areas
    4. Subhra Chakraborty, Johns Hopkins USA
      Immunological Markers of Vaccine Responses to Enterotoxigenic E. Coli
    5. Dr Ira Praharaj, Christian Medical College
      Role of the gut microbiome on mucosal immunity and response to oral vaccines


      Tea coffee break


      Session 2: Protection against enteric diseases, vaccines and other interventions (5 X     20+20 discussion)

      Session Chair: Dr. Firdausi Qadri,
                                    Dr. Dominique Legros


    1. Dr. James Fleckenstein, Washington State University, St Louis
      Discovery and Molecular Characterization of Novel Antigens for ETEC vaccines
    2. Hemanta Koley, NICED, Kolkata
      Studies on Development of Shigella Vaccine by way of Multidimensional Approaches
    3. Dr. Ayan Dey, International Vaccine Institute, Korea
      Utility of Human Circulating Antibody-Producing B Cell as a Predictive
      Measure of Mucosal and Systemic Immunity to Enteric Vaccines
    4. Dr. Mamata Sarkar Chawla , NICED , Kolkata
      Pro-viral role of cellular Heat Shock Proteins during Rotavirus Infection: Exploring drug repurposing to harness novel antiviral therapeutics
    5. Dr. Sajjad Desai, Serum Institute of India
      “Update on Rotasil Vaccine Development”




      Session 3a: Point of care diagnostics (5X20 + 10 discussion)

      Session Chair:  Prof. Colin Stine
                                    Prof. Dr. Meerjady Sabrina Flora


    1. Dr. Naveen Khanna, ICGEB, New Delhi
      Emerging POC technologies
    2. Dr. Ravikrishnan E, IIT Delhi
      Acceleration of culture diagnosis using magnetic nanoparticles and single cell imaging
    3. Dr.Chandrashekhar Nair, Bigtec BIGTEC
    4. Dr. Dhanajaya Dendikuri, Achira Labs
      Microfluidics-based point-of-care testing for diarrhoeal disease detection
    5. Hilleman laboratories

      Session 3b: Arsenic and Health (5X15+15 discussion)

      Session Chair: Dr. Mahfuzur Rahman
                                   Prof. Alan Jackson


    1. Dr. Habibul Ahasan
      Microbiome and arsenic exposure in HEALS cohort.
    2. Dr. Rubhana Raqib, icddr,b, Dhaka
      Effects of long term Arsenic exposure on human health and potential mitigation approaches.
    3. Dr. Faruque Parvez, University of Columbia, USA
      Arsenic exposure and respiratory outcomes in South East Asian Countries
    4. Dr. Bhaskar Das, VIT-University, Tamil Nadu, India
      Arsenic in ground water of the Kolkata Municipal Coorporation (KMC) India: Critical review andmodes of mitigation
    5. Dr. Dipankar Chakraborti, Kolkata, India
      Groundwater Arsenic Contamination in Ganga-Meghna-Brahmaputra Plain: Health Effects, Arsenic in Food Chain, Social, Socio-economic Effects, Future Cancer Risk & Approach for Mitigation

      15:15- 15:40

      Tea /coffee and poster viewing

      15:40 -16:50

      Antimicrobial Resistance(4X15+10 discussion)

      Session Chair: Dr. T Ramamurthy

                                    Dr. Jharna Mandal  


    1. Dr. Kamini Walia, ICMR
      Addressing Antimicrobial Resistance in India: strategies and solutions
    2. Dr. Sabu Thomas, RGCB
      Antimicrobial resistance in V. cholerae and alternative strategies to tackle drug resistance
    3. Dr. Mohammad Aminul Islam icddr,b
      Emergence and spread of antibiotic resistance: a developing country perspective in the global context
    4. Dr Neelam Taneja, PGIMER, Chandigarh
      Evolution of antimicrobial resistance in Shigella spanning three decades, India
    5. EuBiologicals


      Regional Experiences in control of diarrheal     diseases(4X15+10 discussion)

      Session Chair: Prof. Mamatha Ballal,

                                    Dr. James Fleckenstein


    1. Dr. Shanta Dutta, NICED, Kolkata
      Enteric fever: current challenges and future perspectives
    2. Prof. Shiba Kumar Rai, Nepal
      Bacterial diarrhoeal disease in Nepal- Cholera situation
    3. Prof. Diana E. Waturangi, Jakarta, Indonesia
      Surveillance for V. cholerae in food samples in Jakarta, Indonesia
    4. Dr. Raihana, icddr,b
      An account of diarrheal disease situation in Bangladesh

      17:15 -18:00

      Oral poster presentations (10 min X 7)

      Session Chair: Dr. Hubert Endtz

                             Professor VI Mathan

      1. Dr. Debaki Ranjan Howladar, NICED
          Bivalent outer membrane vesicles based immunogen of S. Typhi and Paratyphi A induce adaptive immunity and protective efficacy in mice

      2. Ms. Lekshmi Narendrakumar, RGCB
          Molecular epidemiology of V. cholerae outbreak strains with Haitian ctxB allele isolated from South India

      3. Dr Farhana Khanam, icddr,b
          Characterization of the induced immune responses clinical presentation and antibiotic susceptibility pattern in Bangladeshi S. Paratyphi A bacteremic patients

      4. Sabiha Shaik, University of Hyderabad
          Genomic fine structure of globally dominant E. coli lineage ST131

      5. Dr. Priyadarshini Mukherjee, NICED
          Chitosan Alginate OmpA microparticle- a Shigella protein subunit vaccine against shigellosis

      6. Shah Mohammad Fahim, icddr,b
          Association of Environmental Enteric Dysfunction with Zinc and Iron status in Children of 2 years of age in Bangladesh

      7. Kazi Istiaque Sanin, icddr,b
          Can peer counselling improve complementary feeding practice? A community based cluster randomized controlled trial

      8. Dr. Goutam Choudhury, NICED
          Phosphotransferases encoding gene mphA responsible for emerging azithromycin resistance in Vibrio fluvialis

      9. Dr. Sahana Vasudevan, SASTRA University
          An antivirulence approach to modulate V. cholerae quorum sensing system

      10. Dr. Nitin Kumar, Welcome Trust Sanger Institute
           Taxonomic levels of human gastrointestinal microbiota through the lens of Clostridium difficile


      Poster viewing and Evaluation

      19:30- 21:30



      Day 3 Nov 1, 2017


      8:30 -10 :30 am

      Session 1: What do we miss during decision making on diarrheal and other diseases? (5X20+20 min.  discussion)

      Session Chair: Dr. Martin Mengel, WHO

                                     Dr. Supriya Kumar , BMGF


    1. Dr. Supriya Kumar, BMGF
      Enteric and Diarrheal Disease: an overview of our strategy
    2. Dr. Rashidul Haque, icddr,b, Dhaka, Bangladesh
      Cryptosporidiosis: Consequences for Child Health
    3. Dr. Md Sirajul Islam, icddrb, Dhaka, Bangladesh
      Algal reservoir transmission and prevention of cholera in Bangladesh
    4. Dr. Aliya Naheed, iccdrb
      Double burden of malnutrition among school age children and predictor of childhood obesity in Bangladesh
    5. Dr. Samiran Panda, NICED, Kolkata
      Experiences on Policy related article development in India: Rotavirus gastroenteritis and cholera


      Tea /coffee


      Session 2: Closing ceremony

      Best Poster presentation: Chair: Dr.Hubert Endtz

      Jury board Members:

    • Dr. Asish Mukhopadhyay, NICED;
    • Dr. Prodip Kumar Bardhan, icddr,b;
    • Dr. Nur Haque Alam, icddr,b;
    • Dr. T. Ramamurthy, THSTI;
    • Professor Minnie Mathan, CMC

      Award ceremony:

      Wrap up: (Highlights and new areas): Dr. Firdausi Qadri

      Next ASCODD venue Announcement:



    © 2017 icddr,b. All rights reserved.